NL7003942A - - Google Patents

Info

Publication number
NL7003942A
NL7003942A NL7003942A NL7003942A NL7003942A NL 7003942 A NL7003942 A NL 7003942A NL 7003942 A NL7003942 A NL 7003942A NL 7003942 A NL7003942 A NL 7003942A NL 7003942 A NL7003942 A NL 7003942A
Authority
NL
Netherlands
Application number
NL7003942A
Other versions
NL170631C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US4745A external-priority patent/US3598814A/en
Application filed filed Critical
Publication of NL7003942A publication Critical patent/NL7003942A/xx
Application granted granted Critical
Publication of NL170631C publication Critical patent/NL170631C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7003942A 1969-03-24 1970-03-19 Werkwijze voor het bereiden van farmaceutische preparaten, de gevormde preparaten alsmede werkwijze voor het bereiden van in dergelijke preparaten geschikte benzoxazinonderivaten. NL170631C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82673869A 1969-03-24 1969-03-24
US4745A US3598814A (en) 1970-01-21 1970-01-21 3,3a-dihydro-2h,9h-isoxazolo(3,2-b)(1,3) benzoxazin-9-ones

Publications (2)

Publication Number Publication Date
NL7003942A true NL7003942A (xx) 1970-09-28
NL170631C NL170631C (nl) 1982-12-01

Family

ID=26673406

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7003942A NL170631C (nl) 1969-03-24 1970-03-19 Werkwijze voor het bereiden van farmaceutische preparaten, de gevormde preparaten alsmede werkwijze voor het bereiden van in dergelijke preparaten geschikte benzoxazinonderivaten.

Country Status (11)

Country Link
JP (1) JPS4940240B1 (xx)
AT (1) AT303051B (xx)
CH (1) CH514619A (xx)
DE (1) DE2010418A1 (xx)
DK (1) DK125859B (xx)
ES (1) ES377858A1 (xx)
FI (1) FI50531C (xx)
GB (2) GB1298595A (xx)
NL (1) NL170631C (xx)
NO (1) NO130480C (xx)
SE (1) SE343869B (xx)

Also Published As

Publication number Publication date
NO130480B (xx) 1974-09-09
NO130480C (xx) 1974-12-18
FI50531C (fi) 1976-04-12
GB1298596A (en) 1972-12-06
SE343869B (xx) 1972-03-20
DE2010418A1 (de) 1970-10-01
ES377858A1 (es) 1972-11-01
GB1298595A (en) 1972-12-06
AT303051B (de) 1972-11-10
DK125859B (da) 1973-05-14
CH514619A (fr) 1971-10-31
JPS4940240B1 (xx) 1974-10-31
NL170631C (nl) 1982-12-01
FI50531B (xx) 1975-12-31

Similar Documents

Publication Publication Date Title
AU429630B2 (xx)
AU2355770A (xx)
AU5712069A (xx)
CS152376B2 (xx)
AU427401B2 (xx)
AT308690B (xx)
FI50531B (xx)
AU410358B2 (xx)
AU428131B2 (xx)
AU428129B2 (xx)
AU442538B2 (xx)
AU428074B2 (xx)
AU438128B2 (xx)
AU425297B2 (xx)
AU414607B2 (xx)
AU417208B2 (xx)
AU5598769A (xx)
AU5079269A (xx)
AR203167Q (xx)
CS150255B2 (xx)
AU1036070A (xx)
AU5133369A (xx)
BE740784A (xx)
AU3648969A (xx)
BE759111A (xx)

Legal Events

Date Code Title Description
V4 Lapsed because of reaching the maximum lifetime of a patent